DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo


3.39 0.04 (1.04%)

REAL-TIME: Last trade at

Extended Hours: $3.39 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

VVUS $3.39 1.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.45
Previous Close $3.36
Daily Range $3.28 - $3.45
52-Week Range $3.13 - $10.29
Market Cap $350.7M
P/E Ratio -3.23
Dividend (Yield) $0.00 (0.0%)
Volume 1,681,850
Average Daily Volume 1,958,941
Current FY EPS -$1.06





VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary

Could Arena Pharmaceuticals Inc. Be Running Out of Money?

Biotech stocks running out of money is a common concern for investors of clinical-stage and early commercial stage stocks. Let's take a closer look at Arena Pharmaceuticals' current cash situation and determine whether or not current investors should be worried.

3 Pharma Companies Fighting Obesity

Belviq Sales Dip During Holiday Week, Should Show Steady Progress From Here

Assessing Arena Pharmaceutical Belviq Sales And The Impact Of TV Ads

Orexigen Launches Contrave - Watch For Traction

What To Watch For As Orexigen's Launch Approaches

Emergent BioSolutions Revamps Business to Drive Earnings - Analyst Blog

3 Biotech Stocks Near 52-Week Lows Worth Buying

These may be cheap biotech stocks, but they may not be cheap for long according to the three analysts we asked.

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog

Regeneron's Eye Drug Eylea Wins Another FDA Approval - Analyst Blog

See More VVUS News...

VVUS's Top Competitors

VVUS $3.39 (1.04%)
Current stock: VVUS
JNJ $107.78 (0.69%)
Current stock: JNJ
NVS $92.69 (0.80%)
Current stock: NVS
RHHBY $36.81 (-1.00%)
Current stock: RHHBY